HEPHAISTOS-Pharma raises €2 million (seed) to accelerate the development of their ONCO-Boost treatment
Published on :
31/01/2024
31
January
Jan
01
2024
Altaïr Avocats has advised HEPHAISTOS-Pharma, a key player in the biotechnology sector, in its €2 million Seed fundraising. The deal will enable HEPHAISTOS-Pharma to advance the clinical development of their injectable immunostimulant ONCO-Boost.
Currently in development, ONCO-Boost is an innovative injectable immunostimulant designed to transform cold tumours, which are resistant to the immune system, into warm tumours, which are vulnerable to elimination. This breakthrough could radically transform the treatment of cancer, and positions HEPHAISTOS-Pharma as a future leader in immuno-oncology.
HEPHAISTOS-Pharma aims to establish, over time, strategic partnerships with Big Pharma in order to extend the applications of ONCO-Boost. The funds will enable HEPHAISTOS-Pharma to accelerate its clinical development, industrialise its manufacturing process and open a new subsidiary in Liège, Wallonia.
The fund-raising was orchestrated by Xista Science Ventures and the Fondation Fournier-Majoie, with the participation of Noshaq. It also benefited from the support of Angels Santé and historical investors.
The participants in this transaction:
Altaïr Avocats was involved in the:
Corporate with a team composed of: Philippe Beauregard, partner, and Jeanne Mucchielli, associate.
At the same time, the new investors were advised by Jones Day, represented by partner Jean-Gabriel Griboul and associate Gabriel Saint-Paul.
History
-
HEPHAISTOS-Pharma raises €2 million (seed) to accelerate the development of their ONCO-Boost treatment
Published on : 31/01/2024 31 January Jan 01 2024Deals EN
Altaïr Avocats has advised HEPHAISTOS-Pharma, a key player in the biotechnolo...
-
Newheat raises €30 million to accelerate its energy transition in Europe
Published on : 28/11/2023 28 November Nov 11 2023Deals EN
Altaïr Avocats supported Newheat in its recent €30 million fundraising. This... -
IRDI Capital Investissement and Banque des Territoires are participating in the €4M financing of the startup Abelio.
Published on : 09/10/2023 09 October Oct 10 2023Deals EN
Altaïr Avocats has advised IRDI Capital Investissement and Banque des Territo... -
QL Clean acquires Bretagne Sud Renovation
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats provided legal counsel to QL Clean in its acquisition of Breta... -
Toopi Organics raises €11m from VisVires New Protein, european impact funds, BNP développement and existing investors
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats supported lead investor VisVires New Protein in raising €11m f... -
QL Clean acquires the savary group and strengthens its position in the energy solutions market
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats advised the QL Clean investment consortium, led by Jean-Charle... -
BT2i and JV Group: A strategic merger under the guidance of Tikehau capital
Published on : 22/06/2023 22 June Jun 06 2023Deals EN
Altaïr Avocats assisted JV Group and its management in their merger with BT2I... -
So Deck pursues external growth and raises €1.5 million from IRDI Capital Investissement and a Bordeaux-based industrialist
Published on : 31/05/2023 31 May May 05 2023Deals EN
Altaïr Avocats assisted IRDI CAPITAL INVESTISSEMENT in raising 1.5 million €... -
VitiRev Innovation, Demeter and BNP Paribas Solar Impulse acquire a stake in Axioma, specialized in the production of bio-stimulants, as part of a €15M financing operation
Published on : 31/03/2023 31 March Mar 03 2023Deals EN
Altaïr Avocats advises the new investors in the context of the opening of the...